Benzinga – MINDCURE's "Desire Project" uses MDMA to Treat Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women

Mental health is a major problem, and MINDCURE is tackling it with the Desire Project. The company is using its team of experts to test MDMA for HSDD treatment in premenopausal women, a condition affecting 14% of U.S. women. MDMA is showing promise with PTSD and other areas and is believed to treat the root causes of HSDD.

Access the article here.